Economic Evaluation of a 100% Whey-Based Partially Hydrolyzed Formula for the Prevention of Atopic Dermatitis Among Swiss Children: Preliminary Results

Background and aims: An economic analysis was undertaken to determine the cost-effectiveness of a partially hydrolyzed infant formula (PHF-W) (BEBA-HA®, Nestle S.A, Switzerland) compared to standard cow's milk formula (SF) in the prevention of atopic dermatitis (AD) in at-risk Swiss children not exclusively breastfed.